Envista Holdings (NVST) Change in Accured Expenses (2018 - 2026)
Envista Holdings (NVST) recorded quarterly Change in Accured Expenses of -$39.8 million in Q2 2026, down 289.52% quarter-over-quarter from $21.0 million in Q4 2025, and down 5075.0% on a YoY basis from $800000.0 in Q2 2025.
Envista Holdings (NVST) Change in Accured Expenses (2018 - 2026) Analysis & Trends
Envista Holdings' Change in Accured Expenses history runs 9 years deep, the most recent figure standing at -$39.8 million for Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 5075.0% year-over-year to -$39.8 million; the TTM figure through Apr 2026 stood at $75.4 million (down 42.44% YoY), while the FY2025 annual figure was $116.0 million, down 13.75% from the prior year.
- Change in Accured Expenses was -$39.8 million for Q2 2026 at Envista Holdings, down from $21.0 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $52.4 million in Q2 2024 to a low of -$51.5 million in Q2 2022.
- Historically, Change in Accured Expenses has averaged $3.9 million across 5 years, with a median of $4.3 million in 2024.
- The sharpest annual moves came in 2024 and 2026: Change in Accured Expenses jumped 3790.91% in 2024, then slumped 5075.0% in 2026.
- A 5-year view of Change in Accured Expenses shows it stood at -$23.3 million in 2022, then surged by 160.52% to $14.1 million in 2023, then jumped by 148.23% to $35.0 million in 2024, then slumped by 40.0% to $21.0 million in 2025, then tumbled by 289.52% to -$39.8 million in 2026.
- The last three Change in Accured Expenses figures came in at -$39.8 million (Q2 2026), $21.0 million (Q4 2025), and $50.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -284.70 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | - |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -32.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 103.88 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | - |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -151.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | - |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 5.38 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 203.00 Mn |
| 10 | Envista Holdings | 4.06 Bn | 2.98 Bn | 390.10 Mn | -39.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -39.80 Mn |
| Apr 3, 2026 | -39.80 Mn |
| Dec 31, 2025 | 21.00 Mn |
| Dec 31, 2025 | 21.00 Mn |
| Sep 26, 2025 | 50.50 Mn |
| Sep 26, 2025 | 50.50 Mn |
| Jun 27, 2025 | 43.70 Mn |
| Jun 27, 2025 | 43.70 Mn |
| Mar 28, 2025 | 800,000.00 |
| Mar 28, 2025 | 800,000.00 |
| Dec 31, 2024 | 35.00 Mn |
| Dec 31, 2024 | 35.00 Mn |
| Sep 27, 2024 | 42.80 Mn |
| Sep 27, 2024 | 42.80 Mn |
| Jun 28, 2024 | 52.40 Mn |
| Jun 28, 2024 | 52.40 Mn |
| Mar 29, 2024 | 4.30 Mn |
| Mar 29, 2024 | 4.30 Mn |
| Dec 31, 2023 | 14.10 Mn |
| Dec 31, 2023 | 14.10 Mn |